BRIEF-Century Therapeutics Q3 Net Income USD -23.453 Million Vs. IBES Estimate USD -24.3 Million
Nov 12 (Reuters) - Century Therapeutics Q3 operating income USD -25.206 million vs. IBES estimate USD -24.7 million.
Related stories
US Dollar Edges Higher Against Canadian Dollar
The US dollar nudged higher against Canada's loonie, with rate-hike expectations and rising oil prices cited in the headline.
M impact | FX | Nov 12, 2026, 06:29 PM UTC
First Capital NAV per Share Falls 2.3% in Third Quarter to EUR 27.4
First Capital NAV per Share Falls 2.3% in Third Quarter to EUR 27.4 First Capital's total net as
L impact | FX | Nov 12, 2026, 05:15 PM UTC
EURO DROPS TO LOWEST AGAINST US DOLLAR SINCE APRIL 2025, LAST DOWN 0.27% AT $1.1059
L impact | FX | Nov 12, 2026, 04:21 PM UTC
Brazilian real weakens more than 1% against US dollar
M impact | FX | Nov 12, 2026, 03:50 PM UTC
Paysafe Stock Plunges Post Q3 Report — CEO Says Market Headwinds Exceeded Expectations
Paysafe (PSFE) shares were on track to hit all-time lows on Thursday, falling approximately 30% in premarket trading after the payments company reported weaker-than-expected third
L impact | FX | Nov 12, 2026, 02:13 PM UTC
Convera Says Fed Rate-Rise Expectations Should Support Dollar
Convera’s market insights team says stronger-than-expected U.S. jobs and inflation data have raised expectations for further Fed rate increases, likely keeping the dollar elevated.
M impact | FX | Nov 12, 2026, 01:09 PM UTC